Collaboration between the
public academy and pharmaceuticals

Supported by the Innovative Medicines Initiative (IMI)


Research for the development of
precision medicine strategies


Investigating systemic
autoimmune diseases…

Systemic lupus erythematosus, systemic sclerosis, Sjögren’s syndrome,
rheumatoid arthritis, primary antiphospholipid syndrome , mixed connective tissue disease

  • Welcome to PRECISESADS

    PRECISESADS is an EU project formed by 21 academic, 2 SMEs and 5 industrial partners from 12 countries spread right across Europe, planned for 5 years with a budg...
    Read more
  • UPDATE! News & Events

    PRECISESADS Conference
    "Genomics of Complex Diseases:
    New Challenges”

    Granada, Spain, March 10-11, 2016

    Read more
  • PRECISESADS Partner profile

    IDIBAPS
    The fundamental mission of IDIBAPS is to combine clinical research of proven quality with high-level basic research.
    Read more

About PRECISESADS

Inflammatory autoimmune diseases such as rheumatoid arthritis and lupus affect 1-3% of the population, and while treatments exist, these are costly and have a number of serious side effects. There is growing evidence that many of these conditions may be incorrectly classified. The PRECISESADS project will study 2 500 people with various autoimmune diseases, gathering data on the molecular causes of their disease as well as their clinical symptoms. Using this information, they will pave the way for a new classification of these diseases, something that will allow doctors to offer patients more personalised treatments at an earlier stage of their disease.

IMI PRECISESADS, Bayer Pharma

Latest Project News

    • 01 APR 16
    • 0
    PRECISESADS General Assembly in Granada, 9th of March 2016

    PRECISESADS General Assembly in Granada, 9th of March 2016

    The annual general assembly of the PRECISESADS project took place in Granada on March 2016. More than 70 participants representing the 28 members of the consortium and advisory board have discussed the latest project updates and future steps, including the preparation of the IMI review meeting in Brussels.

Events

  • Information for Patients & Patients Associations

    General information, list of patients associations, …

Project partners